The Hemophilia Alliance
Definitive Homecare Solutions, Ltd.
FOR IMMEDIATE RELEASE
The Hemophilia Alliance and Definitive Homecare Solutions Announce Strategic Alliance
Industry Leading CPR+ Software to be Made Available to Alliance Members
Lansdale, PA and Columbus, Ohio, August 19, 2009–The Hemophilia Alliance, a non-profit organization serving hemophilia treatment centers nationwide, and Definitive Homecare Solutions, the developer of CPR+ home infusion and specialty pharmacy software, announced today an agreement to offer CPR+ software products to The Hemophilia Alliance’s members at preferred pricing.
“Our mission is to provide member Hemophilia Treatment Center with resources and services to sustain the Comprehensive Care Model for individuals with bleeding and clotting disorders,” said Joe Pugliese, President of The Hemophilia Alliance. “With its leading CPR+ home infusion and specialty pharmacy software, Definitive Homecare Solutions provides a comprehensive business management software solution for specialty pharmacies, with specific functions to meet the unique needs of hemophilia treatment centers. We are pleased to be able to make that solution available to our participating members with preferred pricing.”
The Hemophilia Alliance supports its 73 members with various resources and services, including purchasing benefits for enrolled participating members. Hemophilia treatment centers have specialized pharmacy needs for supplying hemophilia patients with regular infusions of the coagulation factors, usually in their homes, to control the disorder. CPR+ is the leading business management software system for infusion pharmacies, including hemophilia treatment centers.
“We have had the privilege of being the technology partner of many of The Hemophilia Alliance’s members for years and have developed CPR+ to efficiently handle the specific inventory and patient management challenges faced by specialty pharmacies dispensing factor,” said Darren Young, Definitive Homecare Solutions’ Director of Sales. “We are pleased to join with The Hemophilia Alliance in bringing new benefits to our existing Alliance customers, and we look forward to being a partner with all Alliance members.”
Among the patient management challenges facing hemophilia treatment centers is the need to separately track inventories covered under Section 340B of the Public Health Service Act, a federal discount drug program designed to help fund the clinical services provided by covered entities like comprehensive hemophilia treatment centers. The Hemophilia Alliance assists its members with enrolling in the program. Definitive Homecare’s CPR+ software provides users with the ability to separately track these patients and the factor products dispensed to these patients, as required by the program.
The Hemophilia Alliance and Definitive Homecare Solutions will participate in joint marketing efforts to promote CPR+ and the benefits of the program to the Alliance’s participating members.
About Definitive Homecare Solutions
Definitive Homecare Solutions, Ltd. develops and licenses its business and patient management software solution, CPR+ to home infusion, specialty pharmacy, and HME providers. Founded in 1993, Definitive Homecare has grown to be a leading provider of enterprise management software to the homecare industry by providing technology to reduce costs and improve efficiencies in patient management, e-billing, inventory control, and revenue enhancement. With offices in Columbus, Ohio and Irvine, California, Definitive Homecare currently supports more than 850 homecare locations nationwide. For more information, visit http://www.cprplus.com.
About The Hemophilia Alliance
The Alliance is a not-for-profit organization that currently comprises 73 Hemophilia Treatment Centers. The purpose of the Alliance is to assist its members in providing outstanding care for their patients. The Hemophilia Alliance provides member Hemophilia Treatment Centers with resources and services to sustain the Comprehensive Care Model for individuals with bleeding and clotting disorders. For more information, visit http://www.hemoalliance.org.